News
Events
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact
Events
Read our news
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact us
Extraordinary Measures Press Release
The IPA has issued the following press release in regard to the film, Extraordinary Measures. (Download PDF, 393...
Author:
IPA
Archive
January 20, 2010
IPA/Erasmus MC Pompe Patient Questionnaire – an Update
The International Pompe Association (IPA) encourages patients to participate in the IPA/Erasmus MC Pompe Survey. The survey is...
Author:
IPA
Archive
December 14, 2009
Pompe Program Update
Genzyme would like to provide an update to the US Pompe community about the status of the Alglucosidase...
Author:
Genzyme
Archive
December 3, 2009
Influenza Vaccinations and Pompe Disease
Guidelines from Erasmus Medical Center, the Netherlands As a guideline we recommend that all patients with Pompe disease...
Author:
IPA
Archive
November 26, 2009
Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
CRANBURY, N.J., Sept 30, 2009 —Amicus Therapeutics today announced it plans to initiate a Phase 1 study of...
Author:
Amicus
Archive
September 30, 2009
IPA Feedback Survey: Response to Myozyme Supply Disruption
Background Throughout the second half of 2008 board members of the International Pompe Association worked closely with the...
Author:
IPA
Archive
July 7, 2009
Pompe Program Update
Background In February 2009, Genzyme received a Complete Response letter from the FDA in regards to the Biologics...
Author:
Genzyme
Archive
May 22, 2009
Genzyme Submits All Information Requested by FDA for Lumizyme
CAMBRIDGE, Mass. – Genzyme Corporation (Nasdaq: GENZ) announced today that it has submitted the final documentation to address...
Author:
Genzyme
Archive
May 22, 2009
IPA Statement: The End of Myozyme Supply Restrictions
You will no doubt have heard the wonderful news that Myozyme from the Belgian production facility has been...
Author:
IPA
Archive
March 2, 2009
Pompe Program Update
Includes information concerning the supply situation and the FDA’s decision on Lumizyme. To read program update, please click...
Author:
Genzyme
Archive
March 2, 2009
1
…
29
30
31
32
33
…
38